BACKGROUND AND PURPOSE: This study investigated the effect of peroxynitrite (ONOO-) on pressure-induced myogenic activity and vascular smooth muscle (VSM) actin of isolated posterior cerebral arteries (PCAs). METHODS: Histochemical staining of nitrotyrosine (NT) was used to demonstrate the presence of ONOO- in the cerebrovasculature after 1 hour of middle cerebral artery occlusion with 30 minutes of reperfusion. To determine the effect of ONOO- on pressure-induced myogenic activity, third-order PCAs from nonischemic animals were isolated and mounted in an arteriograph chamber. Diameter in response to changes in pressure was determined in the absence and presence of ONOO- (10(-8) to 10(-4) mol/L). Filamentous actin (F-actin) and globular actin (G-actin) were quantified using confocal microscopy in PCAs with and without exposure to ONOO-. RESULTS: NT staining of vascular cells was greater in ischemic brain versus sham animals (56+/-3% versus 35+/-3%; P<0.01). Addition of low concentrations of ONOO- (< or =10(-6) mol/L) to isolated PCAs caused constriction from 129+/-16 microm to 115+/-15 microm (P<0.01), whereas concentrations >10(-6) mol/L caused dilation of spontaneous tone and loss of myogenic activity in the physiological range of 50 to 125 mm Hg, increasing diameter from 130+/-6 to 201+/-5 microm at 75 mm Hg (P<0.01). In addition, the diminished myogenic activity was associated with a 4.5-fold decrease in F-actin content of VSM and a 27% increase in G-actin content (P<0.01). CONCLUSIONS: This study demonstrates that ONOO- affects the myogenic activity of cerebral arteries and causes F-actin depolymerization in VSM, a consequence that could promote vascular damage during reperfusion injury and further brain injury.
BACKGROUND AND PURPOSE: This study investigated the effect of peroxynitrite (ONOO-) on pressure-induced myogenic activity and vascular smooth muscle (VSM) actin of isolated posterior cerebral arteries (PCAs). METHODS: Histochemical staining of nitrotyrosine (NT) was used to demonstrate the presence of ONOO- in the cerebrovasculature after 1 hour of middle cerebral artery occlusion with 30 minutes of reperfusion. To determine the effect of ONOO- on pressure-induced myogenic activity, third-order PCAs from nonischemic animals were isolated and mounted in an arteriograph chamber. Diameter in response to changes in pressure was determined in the absence and presence of ONOO- (10(-8) to 10(-4) mol/L). Filamentous actin (F-actin) and globular actin (G-actin) were quantified using confocal microscopy in PCAs with and without exposure to ONOO-. RESULTS:NT staining of vascular cells was greater in ischemic brain versus sham animals (56+/-3% versus 35+/-3%; P<0.01). Addition of low concentrations of ONOO- (< or =10(-6) mol/L) to isolated PCAs caused constriction from 129+/-16 microm to 115+/-15 microm (P<0.01), whereas concentrations >10(-6) mol/L caused dilation of spontaneous tone and loss of myogenic activity in the physiological range of 50 to 125 mm Hg, increasing diameter from 130+/-6 to 201+/-5 microm at 75 mm Hg (P<0.01). In addition, the diminished myogenic activity was associated with a 4.5-fold decrease in F-actin content of VSM and a 27% increase in G-actin content (P<0.01). CONCLUSIONS: This study demonstrates that ONOO- affects the myogenic activity of cerebral arteries and causes F-actin depolymerization in VSM, a consequence that could promote vascular damage during reperfusion injury and further brain injury.
Authors: Shinichi Asano; Grant C O'Connell; Kent C Lemaster; Evan R DeVallance; Kayla W Branyan; James W Simpkins; Jefferson C Frisbee; Taura L Barr; Paul D Chantler Journal: Exp Physiol Date: 2017-09-02 Impact factor: 2.969
Authors: Brandi M Wynne; Hicham Labazi; Zidonia N Carneiro; Rita C Tostes; R Clinton Webb Journal: Eur J Pharmacol Date: 2017-08-20 Impact factor: 4.432
Authors: Maha Coucha; Weiguo Li; Maribeth H Johnson; Susan C Fagan; Adviye Ergul Journal: Am J Physiol Heart Circ Physiol Date: 2013-10-04 Impact factor: 4.733
Authors: Marilyn J Cipolla; Julie G Sweet; Natalia I Gokina; Sheryl L White; Mark T Nelson Journal: J Cereb Blood Flow Metab Date: 2013-06-19 Impact factor: 6.200